SynthesisFrontiers in public health2025
Seroprevalence and risk factors of Chikungunya in Ethiopia: a systematic review and meta-analysis.
Synthesis in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Global resurgence of Chikungunya virus: outbreak drivers and emerging solutions.Emerging microbes & infections · 2026Review
- Adulticidal and repellent activities of traditionally used Ethiopian plants against Anopheles arabiensis and Aedes aegypti.Tropical medicine and health · 2026Article
- Chikungunya virus seroprevalence among febrile patients in selected health facilities in Mount Elgon region, Kenya.PLoS neglected tropical diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The resurgence of the Chikungunya virus has led to public health concerns due to frequent epidemics worldwide. Chikungunya was first detected in Ethiopia in 2016, and it has been identified in various regions. However, the current status of the disease in Ethiopia remains unknown, underscoring the need for updated information. Objective: To provide up-to-date epidemiological data on the status of Chikungunya in Ethiopia. Methods: A systematic review and meta-analysis were conducted using the PubMed, Scopus, and Google Scholar databases in accordance with the PRISMA guidelines, the literature search was conducted from September to October 2024. The search terms used included 'Chikungunya,' 'Chikungunya Virus,' 'Prevalence,' 'Seroprevalence,' 'Risk Factor,' and 'Ethiopia.' The inclusion criteria covered online articles published between 2016 and 2024 in English and published in Ethiopia. The quality assessment involved independent expert evaluations, and publication bias was assessed using Begg's and Egger's tests. The analysis was performed using STATA 17 software. Results: A total of five articles met the eligibility criteria and were included in the data extraction. The pooled seroprevalence of Chikungunya in Ethiopia was 24.0%. The highest seroprevalence was reported in the Southern Nations, Nationalities, and Peoples' Region (SNNPR), at 43.6%, while the lowest seroprevalence was in Dire Dawa, at approximately 12.0%. Factors such as occupation, education, age, and sex contributed to the variation in seroprevalence of the disease. Subgroup meta-analysis revealed heterogeneity across the types of studies included. No indications of publication bias or small-study effects were found according to Begg's test or Egger's test. Conclusion and relevance: The pooled prevalence of Chikungunya underscores its significance in Ethiopia, necessitating proactive monitoring, active viral disease surveillance, and robust health system enforcement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.